Stocks Breaking Stillness on Analysts Estimates: Synergy Pharmaceuticals Inc. (NASDAQ:SGYP)

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) under comprehensive financial analysis presented as an active mover. Shares decreased -3.43% to trade at $5.07 in recent trading session. The firm has floated short ration of 20.02%, hold to candle to sentiment indicator of Short Ratio, which was 6.35. It has price to book ratio of 25.35, which gauges the market price of a share over its book value.

Analysts Rating

Fundamentalist can give brighter side of a picture but an analyst can glow the darker parts stored in any investment. Let us view how analysts have ranked SGYP in recent few months. In ratings table the SGYP given BUY ratings by 5 analysts in current phase and 2 analysts suggest it as overweight security. While 1 number of analysts gave ratings for HOLD in current. As per remarks given by WSJ, overall consensus pool recommends it as Buy security.

The stock was assessed in terms of profitability as current quarter EPS estimate trends showed $-0.18 at current month while compared with $-0.16 in a month ago. The stock next year first quarter current estimate trend for EPS was for $-0.15 and on annual basis FY 2016 estimate trends at current was for $-0.50 as compared to one month ago of $-0.47, and for next year per share earnings estimates have $-0.04.

The returns on assets were -182.00% that gives an idea about how efficient management is at using its assets to generate earnings. It has returns on equity of -876.70%, which is measuring profitability by disclosing how much profit generates by SGYP with the shareholders’ money.

The firm attains analyst recommendation of 1.70 on scale of 1-5. The co has price volatility of 4.14% for a week and 5.26% for a month. Narrow down focus to firm performance, its weekly performance was -3.24% and monthly performance was -19.91%. The stock price of SGYP is moving down from its 20 days moving average with -8.79% and isolated negatively from 50 days moving average with -15.86%.

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) current ratio calculated as 3.00, this value is acceptable if it lies in 1.3% to 3%. But it varies industry to industry. To strengthen these views, active industry firm has Quick Ratio of 2.80, which indicates firm has sufficient short-term assets to cover its immediate liabilities. In addition, the firm has debt to equity ratio of 0.61, sometimes it remain same with long term debt to equity ratio.


About Blake Escott

Blake Escott holds junior writer position in SWR. Before joining Streetwise Report, he was a freelance content Writer. He has high-level copywriting experience and particularly experienced in proofreading and editing. He covers news about different companies including all US market sectors. Interests: Commodities, Energy stocks, Sector-wise Stocks analysis, Utilities

Leave a Reply

Your email address will not be published. Required fields are marked *